Get the Stockscreener App
1.52
2.01%
0.03
Cerus Corp stock is traded at $1.52, with a volume of 126.91K.
It is up +2.01% in the last 24 hours and down -0.65% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.49
Open:
$1.5
24h Volume:
126.91K
Relative Volume:
0.10
Market Cap:
$34.08M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-7.2381
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
-7.88%
1M Performance:
-0.65%
6M Performance:
+15.15%
1Y Performance:
-9.52%
1-Day Range:
$1.48
$1.555
1-Week Range:
$1.48
$1.665
52-Week Range:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.52 | 286.21M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
129.33 | 226.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.12 | 137.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.87 | 129.29B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
96.10 | 147.09B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
71.30 | 32.35B | 20.25B | 2.29B | 1.40B | 4.8366 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Senvest Management LLC Has $5.65 Million Stock Position in Cerus Corporation $CERS - MarketBeat
What makes Cerus Corporation (CU2) stock appealing to growth investorsEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Why Cerus Corporation (CU2) stock appears on watchlists2025 Sector Review & Smart Investment Allocation Insights - newser.com
Why Cerus Corporation (CU2) stock stays resilientMarket Volume Report & Verified Trade Idea Suggestions - newser.com
How Cerus Corporation stock reacts to bond yieldsJuly 2025 Review & Technical Buy Zone Confirmation - newser.com
Is Cerus Corporation (CU2) stock safe for risk averse investors2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
Is Cerus Corporation stock positioned well for digital economyBuy Signal & Low Drawdown Trading Strategies - newser.com
How Cerus Corporation stock benefits from strong dollarMarket Performance Summary & Fast Moving Stock Watchlists - newser.com
How Cerus Corporation (CU2) stock performs in volatility spikes - newser.com
Will Cerus Corporation (CU2) stock outperform global peersJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Is Cerus Corporation stock a good choice for value investorsEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com
Is Cerus Corporation stock resilient to inflationBond Market & Stepwise Entry/Exit Trade Alerts - newser.com
How sustainable is Cerus Corporation stock dividend payout2025 Big Picture & Fast Gain Swing Alerts - newser.com
Published on: 2025-11-19 02:57:58 - newser.com
Why Cerus Corporation (CU2) stock attracts wealthy investorsRecession Risk & Smart Swing Trading Techniques - newser.com
Relative strength of Cerus Corporation in sector analysisWeekly Gains Report & Accurate Intraday Trade Tips - newser.com
How Cerus Corporation (CU2) stock responds to job market shiftsWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Published on: 2025-11-18 16:38:08 - newser.com
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
0.04%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):